PPARα has been found to be upregulated in endometrial cancer cells, while the PPARα ligand fenofibrate seems to inhibit cellular proliferation, induce apoptosis and negatively influence angiogenesis in endometrial cancer. Here, PPARA is linked to endometrial cancer.